FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:141-144 July 13, 2000 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

On both sides of the Atlantic, revolutionary claims have been made about the ultimate impact of genetics on clinical medicine. John Bell at Oxford has asserted that "within the next decade genetic testing will be used widely for predictive testing in healthy people and for diagnosis and management of patients. . . . The excitement in the field has shifted to the elucidation of the genetic basis of the common diseases."¹ And in the United States the director of the National Human Genome Research Institute, Francis Collins, has stated that the good that would come from mapping the human genetic . . . [Full Text of this Article]

Penetrance

Tailoring Treatments to Genotypes

The Magnitude of Absolute, Relative, and Attributable Risks

The Degree of Public Interest in Learning about Disease Risks

Conclusions

References

Related Letters:

Will Genetics Revolutionize Medicine?
Sotos J. G., Rienhoff H. Y., Block G. D., Aulisio M. P., Khoury M. J., Ference B. A., Chauhan M. S., Izumo S., Holtzman N. A., Marteau T. M.
Extract | Full Text  
N Engl J Med 2000; 343:1496-1498, Nov 16, 2000. Correspondence

This article has been cited by other articles:

• Pharoah, P. D.P., Antoniou, A. C., Easton, D. F., Ponder, B. A.J. (2008). Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer. NEJM 358: 2796-2803 [Abstract] [Full Text]  
• Holtzman, N. A (2007). The strange malady of Alessandro's uncle. BMJ 335: 1306-1307 [Full Text]  
• Li, Y., Zagato, L., Kuznetsova, T., Tripodi, G., Zerbini, G., Richart, T., Thijs, L., Manunta, P., Wang, J.-G., Bianchi, G., Staessen, J. A. (2007). Angiotensin-Converting Enzyme I/D and {alpha}-Adducin Gly460Trp Polymorphisms: From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome. Hypertension 49: 1291-1297 [Abstract] [Full Text]  
• Khoury, M. J, Little, J., Gwinn, M., Ioannidis, J. P. (2007). On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 36: 439-445 [Abstract] [Full Text]  
• Horst, M. (2007). Public Expectations of Gene Therapy: Scientific Futures and Their Performative Effects on Scientific Citizenship. Science Technology Human Values 32: 150-171 [Abstract]  
• Hall, W. D (2007). A research agenda for assessing the potential contribution of genomic medicine to tobacco control. Tobacco Control 16: 53-58 [Abstract] [Full Text]  
• Petersen, A. (2006). The genetic conception of health: is it as radical as claimed?. Health (London) 10: 481-500 [Abstract]  
• Ioannidis, J. P. A., Trikalinos, T. A., Khoury, M. J. (2006). Implications of Small Effect Sizes of Individual Genetic Variants on the Design and Interpretation of Genetic Association Studies of Complex Diseases. Am J Epidemiol 164: 609-614 [Abstract] [Full Text]  
• Li, Y., Thijs, L., Kuznetsova, T., Zagato, L., Struijker-Boudier, H., Bianchi, G., Staessen, J. A. (2005). Cardiovascular Risk in Relation to {alpha}-Adducin Gly460Trp Polymorphism and Systolic Pressure: A Prospective Population Study. Hypertension 46: 527-532 [Abstract] [Full Text]  
• Kerruish, N J, Robertson, S P (2005). Newborn screening: new developments, new dilemmas. J. Med. Ethics 31: 393-398 [Abstract] [Full Text]  
• Halliday, J. L, Collins, V. R, Aitken, M. A., Richards, M. P M, Olsson, C. A (2004). Genetics and public health--evolution, or revolution?. J. Epidemiol. Community Health 58: 894-899 [Abstract] [Full Text]  
• Juengst, E. T. (2004). FACE Facts: Why Human Genetics Will Always Provoke Bioethics. J Law Med Ethics 32: 267-275  
• Peters, N., Rose, A., Armstrong, K. (2004). The Association between Race and Attitudes about Predictive Genetic Testing. Cancer Epidemiol. Biomarkers Prev. 13: 361-365 [Abstract] [Full Text]  
• Stevens, J. (2003). Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation. Journal of Health Politics, Policy and Law 28: 1033-1088 [Abstract]  
• Knottnerus, J. (2003). Community genetics and community medicine. Fam Pract 20: 601-606 [Abstract] [Full Text]  
• Col, N. F. (2003). The Use of Gene Tests to Detect Hereditary Predisposition to Chronic Disease: Is Cost-Effectiveness Analysis Relevant?. Med Decis Making 23: 441-448 [Abstract]  
• Mike, V. (2003). Evidence and the Future of Medicine. Eval Health Prof 26: 127-152 [Abstract]  
• Little, J., Khoury, M. J., Bradley, L., Clyne, M., Gwinn, M., Lin, B., Lindegren, M.-L., Yoon, P. (2003). The Human Genome Project Is Complete. How Do We Develop a Handle for the Pump?. Am J Epidemiol 157: 667-673 [Full Text]  
• Cooper, R. S., Psaty, B. M. (2003). Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?. ANN INTERN MED 138: 576-580 [Abstract] [Full Text]  
• Porta, M. (2003). The genome sequence is a jazz score. Int J Epidemiol 32: 29-31 [Full Text]  
• Peters, R. J.G., Boekholdt, S. M. (2002). Gene Polymorphisms and the Risk of Myocardial Infarction -- An Emerging Relation. NEJM 347: 1963-1965 [Full Text]  
• Burke, W. (2002). Genetic Testing. NEJM 347: 1867-1875 [Full Text]  
• Ruilope, L. M. (2002). The Kidney as a Sensor of Cardiovascular Risk in Essential Hypertension. J. Am. Soc. Nephrol. 13: S165-168 [Abstract] [Full Text]  
• Gollust, S. E., Hull, S. C., Wilfond, B. S. (2002). Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing. JAMA 288: 1762-1767 [Abstract] [Full Text]  
• Holtzman, N A (2002). Genetics and social class. J. Epidemiol. Community Health 56: 529-535 [Abstract] [Full Text]  
• Hall, W, Madden, P, Lynskey, M (2002). The genetics of tobacco use: methods, findings and policy implications. Tobacco Control 11: 119-124 [Abstract] [Full Text]  
• Rees, J. (2002). Complex Disease and the New Clinical Sciences. Science 296: 698-700 [Abstract] [Full Text]  
• Frimat, L., Kessler, M. (2002). Controversies concerning the importance of genetic polymorphism in IgA nephropathy. Nephrol Dial Transplant 17: 542-545 [Full Text]  
• Austin, M. A. (2002). Ethical Issues in Human Genome Epidemiology: A Case Study Based on The Japanese American Family Study in Seattle, Washington. Am J Epidemiol 155: 585-592 [Abstract] [Full Text]  
• Swynghedauw, B. (2002). Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes. Eur Heart J 23: 271-273 [Full Text]  
• Murphy, W. M. (2002). Human Carcinogenesis, the New Genetics, and the Practicing Pathologist. INT J SURG PATHOL 10: 1-5 [Abstract]  
• Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., Sadee, W. (2001). Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review. JAMA 286: 2270-2279 [Abstract] [Full Text]  
• Goldie, S. J., Levin, A. R. (2001). Genomics in Medicine and Public Health: Role of Cost-effectiveness Analysis. JAMA 286: 1637-1638 [Full Text]  
• Bovet, P., Paccaud, F., McLeod, H. L., Masoudi, F. A., Havranek, E. P., Ofili, E., Flack, J., Gibbons, G., Exner, D. V., Domanski, M. J., Cohn, J. N., Schwartz, R. S. (2001). Race and Responsiveness to Drugs for Heart Failure. NEJM 345: 766-768 [Full Text]  
• Kumanyika, S. K., Morssink, C. B., Nestle, M. (2001). Minority Women and Advocacy for Women's Health. Am. J. Public Health 91: 1383-1392 [Abstract] [Full Text]  
• Blumenthal, H. T. (2001). Milestone or Genomania? The Relevance of the Human Genome Project to Biological Aging and the Age-Related Diseases. J. Gerontol. A Biol. Sci. Med. Sci. 56: M529-537 [Full Text]  
• HUNT, C. E. (2001). Sudden Infant Death Syndrome and Other Causes of Infant Mortality . Diagnosis, Mechanisms, and Risk for Recurrence in Siblings. Am. J. Respir. Crit. Care Med. 164: 346-357 [Full Text]  
• Davidoff, F. (2001). The Heartbreak of Drug Pricing. ANN INTERN MED 134: 1068-1071 [Full Text]  
• HEFLER, L. A., TEMPFER, C. B., GREGG, A. R. (2001). Polymorphisms Within the Interleukin-1{beta} Gene Cluster and Preeclampsia. Obstet Gynecol 97: 664-668 [Abstract] [Full Text]  
• Zimmern, R., Emery, J., Richards, T. (2001). Putting genetics in perspective. BMJ 322: 1005-1006 [Full Text]  
• Emery, J., Hayflick, S. (2001). The challenge of integrating genetic medicine into primary care. BMJ 322: 1027-1030 [Full Text]  
• Sturgis, E. M., Dahlstrom, K. R., Guan, Y., Eicher, S. A., Strom, S. S., Spitz, M. R., Wei, Q. (2001). Alcohol Dehydrogenase 3 Genotype Is Not Associated with Risk of Squamous Cell Carcinoma of the Oral Cavity and Pharynx. Cancer Epidemiol. Biomarkers Prev. 10: 273-275 [Abstract] [Full Text]  
• Lenfant, C. (2001). Cardiovascular Research : A Look Into Tomorrow. Circ. Res. 88: 253-255 [Full Text]  
• Sotos, J. G., Rienhoff, H. Y., Block, G. D., Aulisio, M. P., Khoury, M. J., Ference, B. A., Chauhan, M. S., Izumo, S., Holtzman, N. A., Marteau, T. M. (2000). Will Genetics Revolutionize Medicine?. NEJM 343: 1496-1498 [Full Text]  
• N. Re, R. (2000). On the Sequencing of the Human Genome. Hypertension 36: 469-470 [Full Text]